Type II collagen serology: A guide to clinical responsiveness to oral tolerance?

Rheumatology International

Volumn 16, Issue 6, 1997, Pages 237-240

  Gimsa, U ^a   Sieper, J ^b   Braun, J ^b   Mitchison, N A ^a  

^a DEUTSCHES RHEUMA FORSCHUNGSZENTRUM   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Antibodies; Collagen II; Oral tolerance; Rheumatoid arthritis

Indexed keywords

COLLAGEN; IMMUNOGLOBULIN G;

ARTICLE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; IMMUNOLOGY; ORAL DRUG ADMINISTRATION; PREDICTION AND FORECASTING; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; SEROLOGY;

ADMINISTRATION, ORAL; ARTHRITIS, RHEUMATOID; COLLAGEN; IMMUNOGLOBULIN G; PREDICTIVE VALUE OF TESTS; SEROLOGY;

EID: 0030637838     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01375655     Document Type: Article

References (33)

1. Sieper J, Kary S, Sörensen H, Alten R, Eggens U, Hüge W, Hiepe F, Kühne A, Listing J, Ullbrich N, Braun J, Zink A, Mitchison NA (1996) Oral collagen II treatment in early rheumatoid arthritis: a double-blind placebo-controlled randomized trial. Arthritis Rheum 39:41-51
2. Felson D (1994) ACR committee on outcome measures in RA trials: American College of Rheumatology (ACR) preliminary criteria for improvement in rheumatoid arthritis (RA) trials. Arthritis Rheum 37:S 195
3. Trentham DE, Dynesius-Trentham RA, Orav EJ, Combitchi D, Lorenzo C, Sewell KL, Hafler DA, Weiner HL (1993) Effects of oral administration of type II collagen. Science 261:1727-1730
4. Nagler-Anderson C, Bober LA, Robinson ME, Siskind GW, Thorbecke FJ (1986) Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen. Proc Natl Acad Sci USA 83:7443-7446
5. Thompson HSG, Staines NA (1986) Gastric administration of type II collagen delays the onset and severity of collagen-induced arthritis in rats. Clin Exp Immunol 64:581-586
6. Zhang JZ, Lee CSY, Lider O, Weiner HL (1988) Suppression of adjuvant arthritis in Lewis rats by oral administration of type II collagen. J Immunol 145:2489-2493
7. Khare SD, Krco CJ, Griffiths MM, Luthra HS, David CS (1995) Oral administration of an immunodominant human collagen peptide modulates collagen-induced arthritis. J Immunol 155:3653-3659
8. Nussenblatt RB, Whitcup SM, de Smet MD, Caspi RR, Kozhich AT, Weiner HL, Vistica B, Gery I (1996) Intraocular inflammatory disease (uveitis) and the use of oral tolerance: a status report. Ann NY Acad Sci 778:325-337
9. Whitacre CC, Gienapp IE, Meyer A, Cox KL, Javed N (1996) Oral tolerance in experimental autoimmune encephalomyelitis. Ann NY Acad Sci 778:217-227
10. Staines NA, Harper N (1995) Oral tolerance in the control of experimental models of autoimmune disease. Z Rheumatol 54:145-154
11. Weiner HL, Friedman A, Miller A, Khoury SJ, al-Sabbagh A, Santos L, Sayegh M, Nussenblatt RB, Trentham DE, Hafler DA (1994) Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu Rev Immunol 12:809-837
12. Dick AD, Cheng YF, McKinnon A, Liversidge J, Forrester JV (1993) Nasal administration of retinal antigens suppresses the inflammatory response in experimental allergic uveoretinitis. A preliminary report of intranasal induction of tolerance with retinal antigens. Br J Ophthalmol 77:171-175
13. Miller EJ, Rhodes RK (1982) Preparation and characterization of the different types of collagen. Methods Enzymol 82:33-64
14. Dietrich A, Mitchison NA, Raijnavölgyi E, Schneider S (1994) Primed lymphocytes are boosted by type II collagen of their hosts after adoptive transfer. J Autoimmun 7:601-609
15. Boissier MC, Chiocchia G, Ronziere MC, Herbage D, Fournier C (1990) Arthritogenicity of minot cartilage collagens (types IX and XI) in mice. Arthritis Rheum 33:1-8
16. Schuppan D, Rühlmann T, Hahn EG (1985) Radioimmunoassay for human type VI collagen and its application to tissue and body fluids. Anal Biochem 149:238-247
17. Schuppan D, Besser M, Schwarting R, Hahn EG (1986) Radioimmunoassay for the carboxy-terminal cross-linking domain of type IV (basement membrane) procollagen in body fluids. Characterization and application to collagen type IV metabolism in fibrotic liver disease. J Clin Invest 78:241-248
18. Becker J, Schuppan D, Benzian H, Bals T, Hahn EG, Cantaluppi C, Reichart P (1986) Immunohistochemical distribution of collagens IV, V, and VI and of pro-collagens types I and III in human alveolar bone and dentine. J Histochem Cytochem 34:1417-1429
19. Mitchison NA (1996) Adoptive transfer. In: Weir DM, Herzenberg LA, Blackwell LA, Blackwell C, Herzenberg LA (eds) Handbook of experimental immunology. Blackwell Science Inc., Cambridge, Mass, (in press)
20. Charriere G, Hartmann DJ, Vignon E, Ronziere M-C, Herbage D, Ville G (1988) Antibodies to types I, II, IX, and XI collagen in the serum of patients with rheumatic diseases. Arthritis Rheum 31:325-332
21. Rowley M, Tait B, Mackay IR, Cunningham T, Phillips B (1986) Collagen antibodies to denatured collagen and their association with HLA-DR4. Arthritis Rheum 29:174-184
22. Rönnelid J, Lysholm J, Engström-Lauren A, Klareskog L, Heyman B (1994) Local anti-type II collagen antibody production in rheumatoid arthritis synovial fluid. Arthritis Rheum 37:1023-1029
23. Dyer PA, Clague RB, Klouda PT, Firth S, Harris R, Holt PJL (1982) HLA antigens in patients with rheumatoid arthritis and antibodies to native type II collagen. Tissue Antigens 20:394-396
24. Collier DH, Kerwar SS, Garovoy MR, Fye KH, Stobo JD (1984) Anticollagen antibodies and immune response gene products in rheumatoid arthritis. Arthritis Rheum 27:1201-1209
25. Klimiuk PS, Clague RB, Grennan DM, Dyer PA, Smeaton I, Harris R (1985) Autoimmunity to native type II collagen - a distinct genetic subset of rheumatoid arthritis. J Rheumatol 12:865-870
26. Beard HK, Ryvar R, Skingle J, Greenbury CL (1980) Anticollagen antibodies in sera from rheumatoid arthritis patients. J Clin Pathol 33:1077-1081
27. Morgan K, Clague RB, Reynolds I, Davis M (1993) Antibodies to type II collagen in early rheumatoid arthritis. J Rheumatol 32:333-335
28. Bloch K, Bloch D, Stearns M, Walker WA (1977) Intestinal uptake of macromolecules. VI. Uptake of protein antigen in vivo in normal rats and in rats infected with Nippostrongylus brasiliensis or subjected to mild systemic anaphylaxis. Gastroenterology 77:1039-1044
29. Hanson D, Roy M, Green GM, Miller S (1993) Inhibition of orally-induced immune tolerance in mice by prefeeding an endopeptidase inhibitor. Reg Immunol 5:74-76
30. Bjarnason I, Williams P, So A, Zanelli GD, Levi AJ, Gumpel JM, Peters TJ, Ansell B (1984) Intestinal permeability and inflammation in rheumatoid arthritis: effects of non-steroidal antiinflammatory drugs. Lancet II:1171-1173
31. Bjarnason I, Zanelli G, Smith T, Prouse P, Williams P, Smethurst P, Delacey G, Gumpel MJ, Levi AJ (1987) Non-steroidal antiinflammatory drug-induced intestinal inflammation in humans. Gastroenterology 93:1070-1074
32. Michaeli D, Fudenberg HH (1974) The incidence and antigenic specificity of antibodies against denatured human collagen in rheumatoid arthritis. Clin Immunol Immunopathol 2:153-159
33. Ferriss J, Cooper S, Roessner K, Hochberg M (1990) Antibodies to denatured type II collagen in rheumatoid arthritis: negative association with IgM rheumatoid factor. J Rheumatol 17:880-884